| Ident. | Authors (with country if any) | Title |
|---|
| 000009 (2008) |
Misato Hashizume [Japon] ; Masahiko Mihara [Japon] | Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling |
| 000023 (2009) |
Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon] | Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production |
| 000052 (2009) |
Miho Suzuki [Japon] ; Misato Hashizume [Japon] ; Hiroto Yoshida [Japon] ; Masahiko Mihara [Japon] | Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule |
| 000076 (2011) |
Makoto Hirao [Japon] ; Naomi Yamasaki [Japon] ; Hiroki Oze [Japon] ; Kosuke Ebina [Japon] ; Akihide Nampei [Japon] ; Yoshitaka Kawato [Japon] ; Kenrin Shi [Japon] ; Hideki Yoshikawa [Japon] ; Norihiro Nishimoto [Japon] ; Jun Hashimoto [Japon] | Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab |
| 000089 (2013) |
Alfredo Adán [Espagne] ; Marina Mesquida [Espagne] ; Victor Llorenç [Espagne] ; Gerard Espinosa [Espagne] ; Blanca Molins [Espagne] ; Maria V. Hernández [Espagne] ; Laura Pelegrín [Espagne] | Tocilizumab treatment for refractory uveitis-related cystoid macular edema |
| 000143 (2012) |
Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France] | Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis |
| 000154 (2011) |
Atsushi Kaneko [Japon] ; Daihei Kida [Japon] ; Kiwamu Saito [Japon] ; Masami Tsukamoto [Japon] ; Tomotaro Sato [Japon] | Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI |
| 000240 (2013) |
Naoshi Nishina [Japon] ; Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon] | Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression |
| 000241 (2010) |
Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon] | Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study |
| 000256 (2012) |
Tsuyoshi Kasama [Japon] ; Hidekazu Furuya [Japon] ; Ryo Yanai [Japon] ; Kumiko Ohtsuka [Japon] ; Ryo Takahashi [Japon] ; Nobuyuki Yajima [Japon] ; Yusuke Miwa [Japon] ; Kazuo Kobayashi [Japon] | Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome |
| 000298 (2012) |
Yin Liu [États-Unis] ; Yuval Ramot [Israël] ; Antonio Torrelo [Espagne] ; Amy S. Paller [États-Unis] ; Nuo Si [République populaire de Chine] ; Sofia Babay [Israël] ; Peter W. Kim [États-Unis] ; Afzal Sheikh [États-Unis] ; Chyi-Chia Richard Lee [États-Unis] ; Yongqing Chen [États-Unis] ; Angel Vera [Espagne] ; Xue Zhang [République populaire de Chine] ; Raphaela Goldbach-Mansky [États-Unis, Israël] ; Abraham Zlotogorski [Israël] | Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity |
| 000326 (2015) |
Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon] | Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model |
| 000455 (2012) |
Yukihiko Saeki [Japon] ; Eriko Kudo-Tanaka [Japon] ; Shiro Ohshima [Japon] ; Masato Matsushita [Japon] ; So-Ichiro Tsuji [Japon] ; Yu-Ichi Maeda [Japon] ; Maiko Yoshimura [Japon] ; Akane Watanabe [Japon] ; Yoshinori Katada [Japon] ; Yoshinori Harada [Japon] ; Kenji Ichikawa [Japon] ; Yasuo Suenaga [Japon] ; Yusuke Ohta [Japon] ; Shigeto Tohma [Japon] | Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA) |
| 000463 (2010) |
Luis Rodríguez-Rodríguez [Espagne] ; José Ram N Lamas [Espagne] ; Jezabel Varadé [Espagne] ; Pedro L Pez-Romero [Espagne] ; Pilar Tornero-Esteban [Espagne] ; Lydia Abasolo [Espagne] ; Emilio Gomez De La Concha [Espagne] ; Juan Angel Jover [Espagne] ; Elena Urcelay [Espagne] ; Benjamín Fernández-Gutiérrez [Espagne] | Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity |
| 000576 (2013) |
Marco Bigoni [Italie] ; Paola Sacerdote [Italie] ; Marco Turati [Italie] ; Silvia Franchi [Italie] ; Marta Gandolla [Italie] ; Diego Gaddi [Italie] ; Sarah Moretti [Italie] ; Daniele Munegato [Italie] ; Carlo A. Augusti [Italie] ; Elena Bresciani [Italie] ; Robert J. Omeljaniuk [Canada] ; Vittorio Locatelli [Italie] ; Antonio Torsello [Italie] | Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury |
| 000674 (2013) |
Christoph Fiehn [Allemagne] ; Elisabeth Belke-Voss [Allemagne] ; Dietmar Krause [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Rolf Rau [Allemagne] | Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs |
| 000713 (2011) |
M. Korppi [Finlande] ; Me Van Gijn [Pays-Bas] ; K. Antila [Finlande] | Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report |
| 000748 (2012) |
Ariel C. Bulua [États-Unis] ; Douglas B. Mogul [États-Unis] ; Ivona Aksentijevich [États-Unis] ; Harjot Singh [États-Unis] ; David Y. He [États-Unis] ; Larry R. Muenz [États-Unis] ; Michael M. Ward [États-Unis] ; Cheryl H. Yarboro [États-Unis] ; Daniel L. Kastner [États-Unis] ; Richard M. Siegel [États-Unis] ; Keith M. Hull [États-Unis] | Efficacy of etanercept in the tumor necrosis factor receptor–associated periodic syndrome: A prospective, open‐label, dose‐escalation study |
| 000A46 (2013) |
Gleb Slobodin [Israël] ; Lisa Kaly [Israël] ; Regina Peri [Israël] ; Aharon Kessel [Israël] ; Itzhak Rosner [Israël] ; Elias Toubi [Israël] ; Doron Rimar [Israël] ; Nina Boulman [Israël] ; Michael Rozenbaum [Israël] ; Majed Odeh [Israël] | Higher Expression of Latency-Associated Peptide on the Surface of Peripheral Blood Monocytes in Patients with Rheumatoid Arthritis may be Protective Against Articular Erosions |
| 000A51 (2013) |
Christian Gissel [Allemagne] ; Holger Repp [Allemagne] | Cost per responder of TNF-α therapies in Germany |
| 000A53 (2010) |
Hiroto Yoshida [Japon] ; Misato Hashizume [Japon] ; Masahiko Mihara [Japon] | IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis |
